Cwa Asset Management Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Cwa Asset Management Group, LLC
- $2.27 Billion
- Q2 2025
A detailed history of Cwa Asset Management Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 1,430 shares of REGN stock, worth $837,236. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,430Holding current value
$837,236% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,422Shares Held
88.7MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.52 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.95 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.31 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.83 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.24 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...